Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging) (VAMP-Aging)

9. november 2026 opdateret af: Eduardo Tibirica, MD, PhD, National Institute of Cardiology, Laranjeiras, Brazil

Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.

Studieoversigt

Detaljeret beskrivelse

An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

105

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Eduardo Tibirica, MD, PhD
  • Telefonnummer: +55-21-99914-6075
  • E-mail: etibi@uol.com.br

Studiesteder

      • Rio de Janeiro, Brasilien, 22240006
        • Rekruttering
        • Eduardo Tibiriçá
        • Kontakt:
          • Eduardo Tibiriçá, MD, PhD
          • Telefonnummer: 21999146075
          • E-mail: etibi@oul.com.br

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

60 år til 100 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.

Beskrivelse

Inclusion Criteria:

  • Absence of symptoms and history of cardiovascular and cerebrovascular diseases.
  • Baseline blood pressure levels within the normal range (< 140/90 mmHg, according to WHO criteria) and absence of use of antihypertensive medications.

Exclusion Criteria:

  • Diabetes Mellitus: Fasting blood glucose ≥ 126 mg/dL or use of hypoglycemic agents.
  • Smoking: Active or quit less than 5 years ago.
  • Inflammatory Diseases: Autoimmune diseases, active neoplasms, or acute infectious processes.
  • Surgery or trauma in the last 60 days.
  • Renal Dysfunction: Chronic renal failure (estimated by eGFR < 60 mL/min/1.73m²).
  • Medication Use: Chronic use of corticosteroids, immunosuppressants, or drugs with direct action on vascular reactivity (e.g., continuous use of nitrates).

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
elderly (60-80 years)

Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire

Investigation of Systemic Endothelial Microvascular Function

Serving as a marker of systemic muscle strength and sarcopenia.

This test will assess the strength and power of the lower limbs.

Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls.

Overall cognitive function will be assessed using the Mini-Mental State Examination.

very elderly (>80)

Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire

Investigation of Systemic Endothelial Microvascular Function

Serving as a marker of systemic muscle strength and sarcopenia.

This test will assess the strength and power of the lower limbs.

Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls.

Overall cognitive function will be assessed using the Mini-Mental State Examination.

control group: healthy young people aged 20-40 years

Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire

Investigation of Systemic Endothelial Microvascular Function

Serving as a marker of systemic muscle strength and sarcopenia.

This test will assess the strength and power of the lower limbs.

Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls.

Overall cognitive function will be assessed using the Mini-Mental State Examination.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Systemic (cutaneous) microcirculatory reactivity.
Tidsramme: up to 20 minutes

To analyze structural and functional changes in the microcirculation in different ages groups, with emphasis on microvascular endothelial senescence.

up to 20 minutes

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Muscle Strength
Tidsramme: up to 10 minutes

Handgrip Dynamometry Maximum isometric strength will be assessed using a manual hydraulic dynamometer.

up to 10 minutes

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Eduardo Tibirica, MD, PhD, National Institute of Cardiology/Ministry of Health

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

4. november 2026

Primær færdiggørelse (Anslået)

1. december 2029

Studieafslutning (Anslået)

1. december 2029

Datoer for studieregistrering

Først indsendt

22. april 2026

Først indsendt, der opfyldte QC-kriterier

29. april 2026

Først opslået (Faktiske)

4. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

13. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

9. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner